Oxidative Stress as an Underlying Contributor in the Development of Chronic Complications in Diabetes Mellitus
暂无分享,去创建一个
M. Goulart | L. Rabelo | S. Bandeira | L. J. S. da Fonseca | G. S. Guedes | S. M. Vasconcelos | Marília O. F. Goulart | Suziy de M. Bandeira | Lucas José S. da Fonseca | Glaucevane da S. Guedes | Luíza A. Rabelo | Sandra Mary L. Vasconcelos | G. D. S. Guedes
[1] S. Moussa. OXIDATIVE STRESS IN DIABETES MELLITUS , 2008 .
[2] W. Dröge. Free radicals in the physiological control of cell function. , 2002, Physiological reviews.
[3] H. Sies,et al. Oxidative stress: oxidants and antioxidants , 1997, Experimental physiology.
[4] B. Halliwell. Oxidants and human disease: some new concepts 1 , 1987, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[5] M. Cassone-Faldetta,et al. Insulin decreases intracellular oxidative stress in patients with type 2 diabetes mellitus. , 2006, Metabolism: clinical and experimental.
[6] M. A. D. Silva,et al. Marcadores de desequilíbrio redox em sangue de pacientes hipertensos de uma comunidade no Nordeste do Brasil , 2011 .
[7] Sho-ichi Yamagishi,et al. Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes , 2011, Experimental Gerontology.
[8] D. Gelain,et al. Characterization of Blood Oxidative Stress in Type 2 Diabetes Mellitus Patients: Increase in Lipid Peroxidation and SOD Activity , 2012, Oxidative medicine and cellular longevity.
[9] M. Dharmalingam,et al. Oxidative Stress in Obesity and Metabolic Syndrome in Asian Indians , 2011 .
[10] K. Dahl-Jørgensen,et al. Microvascular and macrovascular complications , 2007 .
[11] M. S. Benfato,et al. Markers of redox imbalance in the blood of hypertensive patients of a community in Northeastern Brazil. , 2011, Arquivos brasileiros de cardiologia.
[12] A. Cerami,et al. The biochemistry of the complications of diabetes mellitus. , 1981, Annual review of biochemistry.
[13] V. Núñez,et al. Propuesta de un constructo para evaluar integralmente el estrés oxidativo , 2004 .
[14] A. Lee,et al. Contributions of polyol pathway to oxidative stress in diabetic cataract , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[15] R. Haynes. Diabetic complications , 2009, Journal of general internal medicine.
[16] H. Jelinek,et al. Oxidative DNA damage and obesity in type 2 diabetes mellitus. , 2011, European journal of endocrinology.
[17] Y. Kaneda,et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage , 2000, Nature.
[18] Liegang Liu,et al. Oxidative stress, antioxidant status and DNA damage in patients with impaired glucose regulation and newly diagnosed Type 2 diabetes. , 2007, Clinical science.
[19] A. Piwowar,et al. AOPP and its relations with selected markers of oxidative/antioxidative system in type 2 diabetes mellitus. , 2007, Diabetes research and clinical practice.
[20] Joseph L Evans,et al. Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? , 2003, Diabetes.
[21] H. Uzun,et al. Oxidative lipid, protein, and DNA damage as oxidative stress markers in vascular complications of diabetes mellitus. , 2011, Clinical and investigative medicine. Medecine clinique et experimentale.
[22] A. Nicolosi,et al. Mitochondrial Sources of H2O2 Generation Play a Key Role in Flow-Mediated Dilation in Human Coronary Resistance Arteries , 2003, Circulation research.
[23] Erno Harzheim,et al. Perfil de risco cardíaco no diabetes mellitus e na glicemia de jejum alterada , 2004 .
[24] B. Halliwell,et al. Free radicals in biology and medicine , 1985 .
[25] A. Ross,et al. Reactivity of HO2/O−2 Radicals in Aqueous Solution , 1985 .
[26] E. Wright,et al. Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia , 2006, International journal of clinical practice.
[27] H. Utsumi,et al. Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase. , 2003, Journal of the American Society of Nephrology : JASN.
[28] H. Brismar,et al. Role of oxidative stress in advanced glycation end product-induced mesangial cell activation. , 2002, Kidney international.
[29] S. Chung,et al. Aldose Reductase–Deficient Mice Are Protected From Delayed Motor Nerve Conduction Velocity, Increased c-Jun NH2-Terminal Kinase Activation, Depletion of Reduced Glutathione, Increased Superoxide Accumulation, and DNA Damage , 2006, Diabetes.
[30] Y. Miyazaki,et al. Pancreatic B-cell function is altered by oxidative stress induced by acute hyperglycaemia , 2007, Diabetic medicine : a journal of the British Diabetic Association.
[31] B. Schaan,et al. [Cardiac risk profile in diabetes mellitus and impaired fasting glucose]. , 2004, Revista de saude publica.
[32] T. Yoshikawa,et al. Serum extracellular superoxide dismutase in patients with type 2 diabetes: relationship to the development of micro- and macrovascular complications. , 2003, Diabetes care.
[33] J. Barbosa,et al. [The role of advanced glycation end-products (AGEs) in the development of vascular diabetic complications]. , 2008, Arquivos brasileiros de endocrinologia e metabologia.
[34] V. Monnier,et al. Intervention against the Maillard reaction in vivo. , 2003, Archives of biochemistry and biophysics.
[35] D. Graves,et al. Advanced glycation end products induce apoptosis in fibroblasts through activation of ROS, MAP kinases, and the FOXO1 transcription factor. , 2007, American journal of physiology. Cell physiology.
[36] 野島 秀樹. Effect of aerobic exercise training on oxidative stress in patients with type 2 diabetes mellitus , 2007 .
[37] G. Damante,et al. Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy. , 2000, Diabetes.
[38] Joseph L Evans,et al. The molecular basis for oxidative stress-induced insulin resistance. , 2005, Antioxidants & redox signaling.
[39] D. Leibfritz,et al. Free radicals and antioxidants in normal physiological functions and human disease. , 2007, The international journal of biochemistry & cell biology.
[40] Joseph L Evans,et al. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. , 2002, Endocrine reviews.
[41] Júnia Porto Barbosa,et al. O papel dos produtos finais da glicação avançada (AGEs) no desencadeamento das complicações vasculares do diabetes , 2008 .
[42] I. Majsterek,et al. Evaluation of oxidative stress markers in pathogenesis of diabetic neuropathy , 2012, Molecular Biology Reports.
[43] G. King,et al. The role of oxidative stress in the onset and progression of diabetes and its complications: asummary of a Congress Series sponsored byUNESCO‐MCBN, the American Diabetes Association and the German Diabetes Society , 2001, Diabetes/metabolism research and reviews.
[44] Michael Brownlee,et al. The pathobiology of diabetic complications: a unifying mechanism. , 2005, Diabetes.
[45] C. Ionescu-Tirgoviste,et al. Increase in Total Antioxidant Capacity of Plasma despite High Levels of Oxidative Stress in Uncomplicated Type 2 Diabetes Mellitus , 2012, The Journal of international medical research.
[46] S. Chakraborty,et al. Free Radicals and Cardiovascular Diseases: An Update , 2011 .
[47] Y. Wada,et al. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. , 1997, Kidney international.
[48] K. Griendling,et al. Serial Review : The Role of Oxidative Stress in Diabetes mellitus Serial Review , 2006 .
[49] Uk-Prospective-Diabetes-Study-Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) , 1998, The Lancet.
[50] A. Schmidt,et al. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. , 1995, The Journal of clinical investigation.
[51] D. Ziegler,et al. Oxidative stress and antioxidant defense in relation to the severity of diabetic polyneuropathy and cardiovascular autonomic neuropathy. , 2004, Diabetes care.
[52] L. Rossetti,et al. Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. , 2003, The Journal of clinical investigation.
[53] M. Laakso,et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. , 1998, The New England journal of medicine.
[54] Dean P. Jones. Redefining oxidative stress. , 2006, Antioxidants & redox signaling.
[55] J. Sastre,et al. Xanthine oxidase is involved in free radical production in type 1 diabetes: protection by allopurinol. , 2002, Diabetes.
[56] André L. B. S. Barreiros,et al. Estresse oxidativo: relação entre geração de espécies reativas e defesa do organismo , 2006 .
[57] R. Holman,et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .
[58] E. Araki,et al. Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy. , 2003, Diabetes.
[59] M. Dharmalingam,et al. Oxidative Stress in Type 2 Diabetes with Iron Deficiency in Asian Indians , 2012 .
[60] Teven,et al. MORTALITY FROM CORONARY HEART DISEASE IN SUBJECTS WITH TYPE 2 DIABETES AND IN NONDIABETIC SUBJECTS WITH AND WITHOUT PRIOR MYOCARDIAL INFARCTION , 2000 .
[61] M. Brownlee. Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.
[62] L. Rabelo,et al. Redox unbalance: NADPH oxidase as therapeutic target in blood pressure control. , 2010, Arquivos brasileiros de cardiologia.
[63] T Zima,et al. Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. , 2002, Physiological research.
[64] G. Soliman,et al. Blood lipid peroxidation (superoxide dismutase, malondialdehyde, glutathione) levels in Egyptian type 2 diabetic patients. , 2008, Singapore medical journal.
[65] G. King,et al. Protein kinase C activation and the development of diabetic complications. , 1998, Diabetes.
[66] A. Ergul,et al. Oxidative stress and the use of antioxidants in diabetes : Linking basic science to clinical practice , 2015 .
[67] Ramazan Memişoğulları,et al. Levels of ceruloplasmin, transferrin, and lipid peroxidation in the serum of patients with Type 2 diabetes mellitus. , 2004, Journal of diabetes and its complications.
[68] H. Kaneto,et al. Oxidative stress induces p21 expression in pancreatic islet cells: possible implication in beta-cell dysfunction , 1999, Diabetologia.
[69] L. D. Fonseca,et al. Desbalanço redox: NADPH oxidase como um alvo terapêutico no manejo cardiovascular , 2010 .
[70] E. Bechara,et al. SINGLET OXYGEN-MEDIATED PROTEIN OXIDATION: DAMAGE MECHANISMS, DETECTION TECHNIQUES AND BIOLOGICAL IMPLICATIONS. Proteins are potential targets for singlet molecular oxygen ( , 2006 .
[71] G. King,et al. Mechanisms of cardiovascular complications in diabetes and potential new pharmacological therapies , 2003 .
[72] P. Groop,et al. In vivo endothelial dysfunction characterizes patients with impaired fasting glucose. , 1999, Diabetes care.
[73] M. Fowler. Microvascular and Macrovascular Complications of Diabetes , 2008, Clinical Diabetes.
[74] M. Brownlee,et al. Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes. , 1994, The Journal of clinical investigation.
[75] H Keen,et al. The Diabetes Control and Complications Trial (DCCT). , 1994, Health trends.
[76] J. Hothersall,et al. The use of pholasin as a probe for the determination of plasma total antioxidant capacity. , 2006, Clinical biochemistry.
[77] Tim Nolan,et al. International Diabetes Federation. , 2013, Diabetes research and clinical practice.
[78] A. Ceriello,et al. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[79] B. Sancak,et al. Lipid peroxidation and resistance to oxidation in patients with type 2 diabetes mellitus. , 2004, The Tohoku journal of experimental medicine.
[80] Leqaa A. Moemen,et al. Oxidative Stress And Apoptosis In Relation To The Progression Of Diabetic Retinopathy In Diabetics , 2012 .
[81] P. Mascio,et al. Oxidação de proteínas por oxigênio singlete: mecanismos de dano, estratégias para detecção e implicações biológicas , 2006 .
[82] B. Schaan. O papel da proteína quinase C no desenvolvimento das complicações vasculares do diabetes mellitus , 2003 .
[83] J. M. Moita Neto,et al. Parameters of glycemic control and their relationship with zinc concentrations in blood and with superoxide dismutase enzyme activity in type 2 diabetes patients. , 2011, Arquivos brasileiros de endocrinologia e metabologia.
[84] S. Genuth,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.
[85] D. Giustarini,et al. Biomarkers of oxidative damage in human disease. , 2006, Clinical chemistry.
[86] L. Monnier,et al. Glycemic Variability , 2008, Diabetes Care.